Alx Oncology Holdings
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $868 | $0 |
Gross Profit | -191 | -211 | 434 | -224 |
EBITDA | -26,648 | -30,137 | -28,522 | -30,037 |
EBIT | -26,839 | -30,348 | -28,736 | -30,261 |
Net Income | -25,949 | -30,754 | -29,163 | -30,707 |
Net Change In Cash | 0 | 0 | 868 | 0 |
Free Cash Flow | -23,453 | -24,723 | -32,106 | -25,525 |
Cash | 19,302 | 20,614 | 17,567 | 16,102 |
Basic Shares | 53,445 | 53,359 | 52,802 | 52,693 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -872 | -836 | -1,466 | -736 |
EBITDA | -132,249 | -158,404 | -127,094 | -83,471 |
EBIT | -133,121 | -159,240 | -127,436 | -83,522 |
Net Income | -134,850 | -160,805 | -123,482 | -83,463 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -314,779 | -70,552 | ||
Free Cash Flow | -122,359 | -131,638 | -90,650 | -73,024 |
Cash | 17,567 | 22,406 | 48,822 | 363,667 |
Basic Shares | 52,174 | 42,987 | 40,699 | 40,308 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.49 |
2025-03-31 | -$0.47 |
2024-12-31 | -$0.44 |
